139 related articles for article (PubMed ID: 6777812)
21. The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study.
Jakovljevic M; Pivac N; Mihaljevic-Peles A; Mustapic M; Relja M; Ljubicic D; Marcinko D; Muck-Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):399-402. PubMed ID: 17126974
[TBL] [Abstract][Full Text] [Related]
22. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
[TBL] [Abstract][Full Text] [Related]
23. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Turbott J; Villiger J; Hunter L
Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.
Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK
Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250
[TBL] [Abstract][Full Text] [Related]
25. Fluphenazine plasma levels, dosage, efficacy, and side effects.
Levinson DF; Simpson GM; Lo ES; Cooper TB; Singh H; Yadalam K; Stephanos MJ
Am J Psychiatry; 1995 May; 152(5):765-71. PubMed ID: 7726317
[TBL] [Abstract][Full Text] [Related]
26. Fluphenazine plasma levels and clinical response.
Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
J Clin Psychiatry; 1984 Sep; 45(9):370-3. PubMed ID: 6381472
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients.
Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Benkert O; Hiemke C
Exp Clin Endocrinol; 1994; 102(4):326-33. PubMed ID: 7813605
[TBL] [Abstract][Full Text] [Related]
28. The effect of thioridazine on prolactin levels in acutely schizophrenic patients: challenge-dose and steady-state levels.
Johnson GF; Hunt GE
Aust N Z J Psychiatry; 1980 Jun; 14(2):127-31. PubMed ID: 6932868
[TBL] [Abstract][Full Text] [Related]
29. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
[TBL] [Abstract][Full Text] [Related]
30. High doses of fluphenazine enanthate in schizophrenia. A controlled study.
Dencker SJ; Johansson R; Lundin L; Malm U
Acta Psychiatr Scand; 1978 May; 57(5):405-14. PubMed ID: 354329
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
Kolakowska T; Fraser S; Franklin M; Knox J
Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
[TBL] [Abstract][Full Text] [Related]
32. A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine.
Lo ES; Fein M; Hunter C; Suckow RF; Cooper TB
J Pharm Sci; 1988 Mar; 77(3):255-8. PubMed ID: 3373431
[TBL] [Abstract][Full Text] [Related]
33. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
[TBL] [Abstract][Full Text] [Related]
34. Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys.
Linn GS; Lifshitz K; O'Keeffe RT; Lee K; Camp-Lifshitz J
Psychopharmacology (Berl); 2001 Jan; 153(3):285-94. PubMed ID: 11271400
[TBL] [Abstract][Full Text] [Related]
35. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
Jayaram G; Coyle J; Tune L
J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
[TBL] [Abstract][Full Text] [Related]
36. Lower prolactin bioactivity in unmedicated schizophrenic patients.
Warner MD; Walker AM; D'Souza DC; Lee D; Nasseri D; Peabody CA
Psychiatry Res; 2001 Jul; 102(3):249-54. PubMed ID: 11440775
[TBL] [Abstract][Full Text] [Related]
37. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine.
Dencker SJ; Johansson R; Malm U
Psychopharmacology (Berl); 1988; 94(2):237-41. PubMed ID: 3127851
[TBL] [Abstract][Full Text] [Related]
39. Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.
McCreadie RG; Mackie M; Wiles DH; Jorgensen A; Hansen V; Menzies C
Br J Psychiatry; 1984 Jun; 144():625-9. PubMed ID: 6146373
[TBL] [Abstract][Full Text] [Related]
40. [The plasma prolactin level under fluphenazine treatment (author's transl)].
Hinterhuber H; Platz T; Schwarz S
Wien Med Wochenschr; 1980 Sep; 130(17):566-70. PubMed ID: 7456470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]